$0.8600
-0.0026-0.3%
Last update: Oct 30, 9:26 AM
Phio Pharmaceuticals Corp (PHIO) Stock Price, Quote, News & History
PHIONASDAQ
Phio Pharma stock fell after a recent rally, despite strong Phase 1b trial results showing an 85% response rate. Analysts maintain Buy ratings as shares trade...
You can purchase shares of Phio Pharmaceuticals (NASDAQ:PHIO) through any online brokerage.
Other companies in Phio Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Phio Pharmaceuticals has a consensus price target of $10.67.
The stock price for Phio Pharmaceuticals (NASDAQ: PHIO) is $0.904 last updated October 30, 2026 at 9:26 AM EDT.
There are no upcoming dividends for Phio Pharmaceuticals.
Phio Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Phio Pharmaceuticals.
Phio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762...
